Skip to main content
NCBI home page
Biochemical Journal logoLink to Biochemical Journal
. 2000 Apr 1;347(Pt 1):123–129.

Probing the specificity of cysteine proteinases at subsites remote from the active site: analysis of P4, P3, P2' and P3' variations in extended substrates.

F C Portaro 1, A B Santos 1, M H Cezari 1, M A Juliano 1, L Juliano 1, E Carmona 1
PMCID: PMC1220939  PMID: 10727410

Abstract

We have determined the kinetic parameters for the hydrolysis by papain, cathepsin B and cathepsin L of internally quenched fluorescent peptides derived from the lead peptides Abz-AAFRSAQ-EDDnp [in which Abz and EDDnp stand for o-aminobenzoic acid and N-(2,4-dinitrophenyl)ethylenediamine respectively], to map the specificity of S(4) and S(3) subsites, and Abz-AFRSAAQ-EDDnp, to identify the specificity of S(2)' and S(3)'. Abz and EDDnp were the fluorescent quencher pair. These two series of peptides were cleaved at the Arg-Ser bond and systematic modifications at P(4), P(3), P(2)' and P(3)' were made. The S(4) to S(2)' subsites had a significant influence on the hydrolytic efficiencies of the three enzymes. Only papain activity was observed to be dependent on S(3)', indicating that its binding site is larger than those of cathepsins B and L. Hydrophobic amino acids were accepted at S(4), S(3), S(2)' and S(3)' of the three enzymes. The best substrates for cathepsins L and B had Trp and Asn at P(2)' respectively; variations at this position were less accepted by these enzymes. The best substrates for papain were peptides containing Trp, Tyr or Asn at P(3)'. Basic residues at P(3) and P(4) were well accepted by cathepsin L and papain. We also explored the susceptibility of substrates Abz-AFRSXAQ-EDDnp, modified at P(2)' (X), to human cathepsin B mutants from which one or two occluding loop contacts had been removed. The modifications at His(111) (H111A) and His(110) (H110A) of cathepsin B led to an increase in k(cat) values of one or two orders of magnitude. The hydrolytic efficiencies of these cathepsin B mutants became closer to those of papain or cathepsin L.

Full Text

The Full Text of this article is available as a PDF (141.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Authier F., Posner B. I., Bergeron J. J. Endosomal proteolysis of internalized proteins. FEBS Lett. 1996 Jun 24;389(1):55–60. doi: 10.1016/0014-5793(96)00368-7. [DOI] [PubMed] [Google Scholar]
  2. Berger A., Schechter I. Mapping the active site of papain with the aid of peptide substrates and inhibitors. Philos Trans R Soc Lond B Biol Sci. 1970 Feb 12;257(813):249–264. doi: 10.1098/rstb.1970.0024. [DOI] [PubMed] [Google Scholar]
  3. Berti P. J., Storer A. C. Alignment/phylogeny of the papain superfamily of cysteine proteases. J Mol Biol. 1995 Feb 17;246(2):273–283. doi: 10.1006/jmbi.1994.0083. [DOI] [PubMed] [Google Scholar]
  4. Carmona E., Dufour E., Plouffe C., Takebe S., Mason P., Mort J. S., Ménard R. Potency and selectivity of the cathepsin L propeptide as an inhibitor of cysteine proteases. Biochemistry. 1996 Jun 25;35(25):8149–8157. doi: 10.1021/bi952736s. [DOI] [PubMed] [Google Scholar]
  5. Chagas J. R., Juliano L., Prado E. S. Intramolecularly quenched fluorogenic tetrapeptide substrates for tissue and plasma kallikreins. Anal Biochem. 1991 Feb 1;192(2):419–425. doi: 10.1016/0003-2697(91)90558-b. [DOI] [PubMed] [Google Scholar]
  6. Coulombe R., Grochulski P., Sivaraman J., Ménard R., Mort J. S., Cygler M. Structure of human procathepsin L reveals the molecular basis of inhibition by the prosegment. EMBO J. 1996 Oct 15;15(20):5492–5503. [PMC free article] [PubMed] [Google Scholar]
  7. Cygler M., Sivaraman J., Grochulski P., Coulombe R., Storer A. C., Mort J. S. Structure of rat procathepsin B: model for inhibition of cysteine protease activity by the proregion. Structure. 1996 Apr 15;4(4):405–416. doi: 10.1016/s0969-2126(96)00046-9. [DOI] [PubMed] [Google Scholar]
  8. Drenth J., Jansonius J. N., Koekoek R., Swen H. M., Wolthers B. G. Structure of papain. Nature. 1968 Jun 8;218(5145):929–932. doi: 10.1038/218929a0. [DOI] [PubMed] [Google Scholar]
  9. Drenth J., Kalk K. H., Swen H. M. Binding of chloromethyl ketone substrate analogues to crystalline papain. Biochemistry. 1976 Aug 24;15(17):3731–3738. doi: 10.1021/bi00662a014. [DOI] [PubMed] [Google Scholar]
  10. Duffy M. J. Inhibiting tissue invasion and metastasis as targets for cancer therapy. Biotherapy. 1992;4(1):45–52. doi: 10.1007/BF02171709. [DOI] [PubMed] [Google Scholar]
  11. Esser R. E., Angelo R. A., Murphey M. D., Watts L. M., Thornburg L. P., Palmer J. T., Talhouk J. W., Smith R. E. Cysteine proteinase inhibitors decrease articular cartilage and bone destruction in chronic inflammatory arthritis. Arthritis Rheum. 1994 Feb;37(2):236–247. doi: 10.1002/art.1780370213. [DOI] [PubMed] [Google Scholar]
  12. Fujishima A., Imai Y., Nomura T., Fujisawa Y., Yamamoto Y., Sugawara T. The crystal structure of human cathepsin L complexed with E-64. FEBS Lett. 1997 Apr 21;407(1):47–50. doi: 10.1016/s0014-5793(97)00216-0. [DOI] [PubMed] [Google Scholar]
  13. García-Echeverría C., Rich D. H. Effect of P2' substituents on kinetic constants for hydrolysis by cysteine proteinases. Biochem Biophys Res Commun. 1992 Sep 16;187(2):615–619. doi: 10.1016/0006-291x(92)91239-m. [DOI] [PubMed] [Google Scholar]
  14. García-Echeverría C., Rich D. H. New intramolecularly quenched fluorogenic peptide substrates for the study of the kinetic specificity of papain. FEBS Lett. 1992 Feb 3;297(1-2):100–102. doi: 10.1016/0014-5793(92)80336-f. [DOI] [PubMed] [Google Scholar]
  15. Gauthier F., Moreau T., Lalmanach G., Brillard-Bourdet M., Ferrer-Di Martino M., Juliano L. A new, sensitive fluorogenic substrate for papain based on the sequence of the cystatin inhibitory site. Arch Biochem Biophys. 1993 Nov 1;306(2):304–308. doi: 10.1006/abbi.1993.1516. [DOI] [PubMed] [Google Scholar]
  16. Hasnain S., Hirama T., Huber C. P., Mason P., Mort J. S. Characterization of cathepsin B specificity by site-directed mutagenesis. Importance of Glu245 in the S2-P2 specificity for arginine and its role in transition state stabilization. J Biol Chem. 1993 Jan 5;268(1):235–240. [PubMed] [Google Scholar]
  17. Heinrikson R. L., Meredith S. C. Amino acid analysis by reverse-phase high-performance liquid chromatography: precolumn derivatization with phenylisothiocyanate. Anal Biochem. 1984 Jan;136(1):65–74. doi: 10.1016/0003-2697(84)90307-5. [DOI] [PubMed] [Google Scholar]
  18. Illy C., Quraishi O., Wang J., Purisima E., Vernet T., Mort J. S. Role of the occluding loop in cathepsin B activity. J Biol Chem. 1997 Jan 10;272(2):1197–1202. doi: 10.1074/jbc.272.2.1197. [DOI] [PubMed] [Google Scholar]
  19. Jia Z., Hasnain S., Hirama T., Lee X., Mort J. S., To R., Huber C. P. Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Implications for structure-based inhibitor design. J Biol Chem. 1995 Mar 10;270(10):5527–5533. doi: 10.1074/jbc.270.10.5527. [DOI] [PubMed] [Google Scholar]
  20. Kakegawa H., Nikawa T., Tagami K., Kamioka H., Sumitani K., Kawata T., Drobnic-Kosorok M., Lenarcic B., Turk V., Katunuma N. Participation of cathepsin L on bone resorption. FEBS Lett. 1993 Apr 26;321(2-3):247–250. doi: 10.1016/0014-5793(93)80118-e. [DOI] [PubMed] [Google Scholar]
  21. Kim M. J., Yamamoto D., Matsumoto K., Inoue M., Ishida T., Mizuno H., Sumiya S., Kitamura K. Crystal structure of papain-E64-c complex. Binding diversity of E64-c to papain S2 and S3 subsites. Biochem J. 1992 Nov 1;287(Pt 3):797–803. doi: 10.1042/bj2870797. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Krantz A., Copp L. J., Coles P. J., Smith R. A., Heard S. B. Peptidyl (acyloxy)methyl ketones and the quiescent affinity label concept: the departing group as a variable structural element in the design of inactivators of cysteine proteinases. Biochemistry. 1991 May 14;30(19):4678–4687. doi: 10.1021/bi00233a007. [DOI] [PubMed] [Google Scholar]
  23. Kärgel H. J., Dettmer R., Etzold G., Kirschke H., Bohley P., Langner J. Action of cathepsin L on the oxidized B-chain of bovine insulin. FEBS Lett. 1980 Jun 2;114(2):257–260. doi: 10.1016/0014-5793(80)81128-8. [DOI] [PubMed] [Google Scholar]
  24. Lecaille F., Serveau C., Gauthier F., Lalmanach G. Revisiting the S2 specificity of papain by structural analogs of Phe. FEBS Lett. 1999 Feb 26;445(2-3):311–314. doi: 10.1016/s0014-5793(99)00143-x. [DOI] [PubMed] [Google Scholar]
  25. Musil D., Zucic D., Turk D., Engh R. A., Mayr I., Huber R., Popovic T., Turk V., Towatari T., Katunuma N. The refined 2.15 A X-ray crystal structure of human liver cathepsin B: the structural basis for its specificity. EMBO J. 1991 Sep;10(9):2321–2330. doi: 10.1002/j.1460-2075.1991.tb07771.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Ménard R., Carmona E., Plouffe C., Brömme D., Konishi Y., Lefebvre J., Storer A. C. The specificity of the S1' subsite of cysteine proteases. FEBS Lett. 1993 Aug 9;328(1-2):107–110. doi: 10.1016/0014-5793(93)80975-z. [DOI] [PubMed] [Google Scholar]
  27. Ménard R., Khouri H. E., Plouffe C., Dupras R., Ripoll D., Vernet T., Tessier D. C., Lalberté F., Thomas D. Y., Storer A. C. A protein engineering study of the role of aspartate 158 in the catalytic mechanism of papain. Biochemistry. 1990 Jul 17;29(28):6706–6713. doi: 10.1021/bi00480a021. [DOI] [PubMed] [Google Scholar]
  28. Nägler D. K., Storer A. C., Portaro F. C., Carmona E., Juliano L., Ménard R. Major increase in endopeptidase activity of human cathepsin B upon removal of occluding loop contacts. Biochemistry. 1997 Oct 14;36(41):12608–12615. doi: 10.1021/bi971264+. [DOI] [PubMed] [Google Scholar]
  29. Nägler D. K., Tam W., Storer A. C., Krupa J. C., Mort J. S., Ménard R. Interdependency of sequence and positional specificities for cysteine proteases of the papain family. Biochemistry. 1999 Apr 13;38(15):4868–4874. doi: 10.1021/bi982632s. [DOI] [PubMed] [Google Scholar]
  30. O'Hara B. P., Hemmings A. M., Buttle D. J., Pearl L. H. Crystal structure of glycyl endopeptidase from Carica papaya: a cysteine endopeptidase of unusual substrate specificity. Biochemistry. 1995 Oct 10;34(40):13190–13195. doi: 10.1021/bi00040a034. [DOI] [PubMed] [Google Scholar]
  31. Pliura D. H., Bonaventura B. J., Smith R. A., Coles P. J., Krantz A. Comparative behaviour of calpain and cathepsin B toward peptidyl acyloxymethyl ketones, sulphonium methyl ketones and other potential inhibitors of cysteine proteinases. Biochem J. 1992 Dec 15;288(Pt 3):759–762. doi: 10.1042/bj2880759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Rowan A. D., Mason P., Mach L., Mort J. S. Rat procathepsin B. Proteolytic processing to the mature form in vitro. J Biol Chem. 1992 Aug 5;267(22):15993–15999. [PubMed] [Google Scholar]
  33. Schröder E., Phillips C., Garman E., Harlos K., Crawford C. X-ray crystallographic structure of a papain-leupeptin complex. FEBS Lett. 1993 Jan 2;315(1):38–42. doi: 10.1016/0014-5793(93)81128-m. [DOI] [PubMed] [Google Scholar]
  34. Serveau C., Lalmanach G., Juliano M. A., Scharfstein J., Juliano L., Gauthier F. Investigation of the substrate specificity of cruzipain, the major cysteine proteinase of Trypanosoma cruzi, through the use of cystatin-derived substrates and inhibitors. Biochem J. 1996 Feb 1;313(Pt 3):951–956. doi: 10.1042/bj3130951. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Shaw E. Cysteinyl proteinases and their selective inactivation. Adv Enzymol Relat Areas Mol Biol. 1990;63:271–347. doi: 10.1002/9780470123096.ch5. [DOI] [PubMed] [Google Scholar]
  36. St Hilaire P. M., Willert M., Juliano M. A., Juliano L., Meldal M. Fluorescence-quenched solid phase combinatorial libraries in the characterization of cysteine protease substrate specificity. J Comb Chem. 1999 Nov-Dec;1(6):509–523. doi: 10.1021/cc990031u. [DOI] [PubMed] [Google Scholar]
  37. Storer A. C., Ménard R. Catalytic mechanism in papain family of cysteine peptidases. Methods Enzymol. 1994;244:486–500. doi: 10.1016/0076-6879(94)44035-2. [DOI] [PubMed] [Google Scholar]
  38. Taralp A., Kaplan H., Sytwu I. I., Vlattas I., Bohacek R., Knap A. K., Hirama T., Huber C. P., Hasnain S. Characterization of the S3 subsite specificity of cathepsin B. J Biol Chem. 1995 Jul 28;270(30):18036–18043. doi: 10.1074/jbc.270.30.18036. [DOI] [PubMed] [Google Scholar]
  39. Turk D., Guncar G., Podobnik M., Turk B. Revised definition of substrate binding sites of papain-like cysteine proteases. Biol Chem. 1998 Feb;379(2):137–147. doi: 10.1515/bchm.1998.379.2.137. [DOI] [PubMed] [Google Scholar]
  40. Turk D., Podobnik M., Kuhelj R., Dolinar M., Turk V. Crystal structures of human procathepsin B at 3.2 and 3.3 Angstroms resolution reveal an interaction motif between a papain-like cysteine protease and its propeptide. FEBS Lett. 1996 Apr 22;384(3):211–214. doi: 10.1016/0014-5793(96)00309-2. [DOI] [PubMed] [Google Scholar]
  41. Turk D., Podobnik M., Popovic T., Katunuma N., Bode W., Huber R., Turk V. Crystal structure of cathepsin B inhibited with CA030 at 2.0-A resolution: A basis for the design of specific epoxysuccinyl inhibitors. Biochemistry. 1995 Apr 11;34(14):4791–4797. doi: 10.1021/bi00014a037. [DOI] [PubMed] [Google Scholar]
  42. Varughese K. I., Ahmed F. R., Carey P. R., Hasnain S., Huber C. P., Storer A. C. Crystal structure of a papain-E-64 complex. Biochemistry. 1989 Feb 7;28(3):1330–1332. doi: 10.1021/bi00429a058. [DOI] [PubMed] [Google Scholar]
  43. WILKINSON G. N. Statistical estimations in enzyme kinetics. Biochem J. 1961 Aug;80:324–332. doi: 10.1042/bj0800324. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Yamamoto A., Hara T., Tomoo K., Ishida T., Fujii T., Hata Y., Murata M., Kitamura K. Binding mode of CA074, a specific irreversible inhibitor, to bovine cathepsin B as determined by X-ray crystal analysis of the complex. J Biochem. 1997 May;121(5):974–977. doi: 10.1093/oxfordjournals.jbchem.a021682. [DOI] [PubMed] [Google Scholar]

Articles from Biochemical Journal are provided here courtesy of The Biochemical Society

RESOURCES